ATOS
Price
$0.79
Change
-$0.02 (-2.47%)
Updated
Aug 6 closing price
Capitalization
101.76M
11 days until earnings call
RNTX
Price
$1.14
Change
-$0.01 (-0.87%)
Updated
Aug 7, 10:46 AM (EDT)
Capitalization
26.62M
Interact to see
Advertisement

ATOS vs RNTX

Header iconATOS vs RNTX Comparison
Open Charts ATOS vs RNTXBanner chart's image
Atossa Therapeutics
Price$0.79
Change-$0.02 (-2.47%)
Volume$901.94K
Capitalization101.76M
Rein Therapeutics
Price$1.14
Change-$0.01 (-0.87%)
Volume$2.25K
Capitalization26.62M
ATOS vs RNTX Comparison Chart in %
Loading...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATOS vs. RNTX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATOS is a StrongBuy and RNTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (ATOS: $0.79 vs. RNTX: $1.15)
Brand notoriety: ATOS and RNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATOS: 67% vs. RNTX: 29%
Market capitalization -- ATOS: $101.76M vs. RNTX: $26.62M
ATOS [@Biotechnology] is valued at $101.76M. RNTX’s [@Biotechnology] market capitalization is $26.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATOS’s FA Score shows that 1 FA rating(s) are green whileRNTX’s FA Score has 0 green FA rating(s).

  • ATOS’s FA Score: 1 green, 4 red.
  • RNTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATOS and RNTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATOS’s TA Score shows that 3 TA indicator(s) are bullish while RNTX’s TA Score has 4 bullish TA indicator(s).

  • ATOS’s TA Score: 3 bullish, 6 bearish.
  • RNTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RNTX is a better buy in the short-term than ATOS.

Price Growth

ATOS (@Biotechnology) experienced а -9.66% price change this week, while RNTX (@Biotechnology) price change was -9.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.71%. For the same industry, the average monthly price growth was +9.97%, and the average quarterly price growth was +14.14%.

Reported Earning Dates

ATOS is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+2.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATOS($102M) has a higher market cap than RNTX($26.6M). ATOS YTD gains are higher at: -16.555 vs. RNTX (-49.783). RNTX has higher annual earnings (EBITDA): -26.51M vs. ATOS (-28.04M). ATOS has more cash in the bank: 65.1M vs. RNTX (7.43M). ATOS (0) and RNTX (0) have equivalent revenues.
ATOSRNTXATOS / RNTX
Capitalization102M26.6M383%
EBITDA-28.04M-26.51M106%
Gain YTD-16.555-49.78333%
P/E RatioN/AN/A-
Revenue00-
Total Cash65.1M7.43M876%
Total Debt0N/A-
FUNDAMENTALS RATINGS
ATOS vs RNTX: Fundamental Ratings
ATOS
RNTX
OUTLOOK RATING
1..100
7758
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
7693
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATOS's Valuation (24) in the Medical Specialties industry is in the same range as RNTX (49) in the null industry. This means that ATOS’s stock grew similarly to RNTX’s over the last 12 months.

ATOS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as RNTX (100) in the null industry. This means that ATOS’s stock grew similarly to RNTX’s over the last 12 months.

ATOS's SMR Rating (97) in the Medical Specialties industry is in the same range as RNTX (100) in the null industry. This means that ATOS’s stock grew similarly to RNTX’s over the last 12 months.

ATOS's Price Growth Rating (76) in the Medical Specialties industry is in the same range as RNTX (93) in the null industry. This means that ATOS’s stock grew similarly to RNTX’s over the last 12 months.

ATOS's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as RNTX (100) in the null industry. This means that ATOS’s stock grew similarly to RNTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATOSRNTX
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BZH23.300.20
+0.87%
Beazer Homes USA
VALE9.85-0.02
-0.20%
Vale SA
IONR2.97-0.01
-0.34%
ioneer Ltd
HUN9.24-0.28
-2.94%
Huntsman Corp
ANY0.51-0.02
-3.64%
Sphere 3D Corp

ATOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATOS has been loosely correlated with PDSB. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATOS jumps, then PDSB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATOS
1D Price
Change %
ATOS100%
-2.14%
PDSB - ATOS
42%
Loosely correlated
-1.77%
AXON - ATOS
42%
Loosely correlated
-0.40%
RGNX - ATOS
42%
Loosely correlated
-0.72%
NRIX - ATOS
41%
Loosely correlated
-7.52%
NTLA - ATOS
41%
Loosely correlated
-1.81%
More

RNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNTX has been loosely correlated with NBY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RNTX jumps, then NBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNTX
1D Price
Change %
RNTX100%
-2.12%
NBY - RNTX
35%
Loosely correlated
-3.30%
ERNA - RNTX
27%
Poorly correlated
-0.59%
IKT - RNTX
27%
Poorly correlated
-3.89%
ATOS - RNTX
26%
Poorly correlated
-2.14%
VYGR - RNTX
25%
Poorly correlated
+0.59%
More